Karen C. Wolff

1.6k citations

20 papers · 1.0k indexed · h-index 12

Virology top 5%
- HIV Research and Treatment 7
Organic Chemistry top 5%
Infectious Diseases
- HIV/AIDS drug development and treatment 7
Molecular Biology
- Biochemical and Molecular Research 3
- RNA regulation and disease 2
- RNA Interference and Gene Delivery 2
Plant Science top 10%
Epidemiology
- Pneumocystis jirovecii pneumonia detection and treatment 5
- Respiratory viral infections research 2
Cardiology and Cardiovascular Medicine
- Viral Infections and Immunology Research 2

Co-authors: Kelli Kuhen Jeremy S. Caldwell Hong Yin Yun He Badry BursulayaTao JiangCharles E. Samuel Glenn R. Hicks
Cited by: Virology Organic Chemistry Infectious Diseases
Journals: Journal of the American Chemical Society (1 paper)PLANT PHYSIOLOGY (2 papers)Journal of Virology (1 paper)
Partner nations: United States Germany Colombia

In The Last Decade

Karen C. Wolff

18 papers receiving 1.0k citations

Peers

Countries citing papers authored by Karen C. Wolff

Since Specialization

Citations

This map shows the geographic impact of Karen C. Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen C. Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen C. Wolff more than expected).

Fields of papers citing papers by Karen C. Wolff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen C. Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen C. Wolff. The network helps show where Karen C. Wolff may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Karen C. Wolff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karen C. Wolff Line = papers co-authored together Karen C. Wolff links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Open Source Repurposing Reveals Broad-Spectrum Antiviral Activity of Diphenylureas Viruses ·Ulrich Betz,Robert Garces,Norbert Beier,S. Lindemann,Karen C. Wolff,Laura Riva,Melanie G. Kirkpatrick,Amal Gebara-Lamb,Case W. McNamara,Robert Damoiseaux,Brigitte N. Gomperts,Vaithilingaraja Arumugaswami,Mårten Strand,Yong-Dae Gwon,Mikael Elofsson,Magnus Evander	2025	1
2	Covalent Probes Reveal Small-Molecule Binding Pockets in Structured RNA and Enable Bioactive Compound Design Journal of the American Chemical Society ·Sandra Kovachka,Jielei Wang,Amirhossein Taghavi,Yilin Jia,Taro Asaba,Karen C. Wolff,M. V. MARTÍN,Xueyi Yang,Samantha M. Meyer,Sabine Ottilie,Mina Heacock,Zhong Cheng,Case W. McNamara,Gurudutt Dubey,Arnab K. Chatterjee,Sumit K. Chanda,José Gallego,Jessica L. Childs‐Disney,Matthew D. Disney	2025	0
3	Discovery and Optimization of a Novel Series of Influenza A Virus Replication Inhibitors Targeting the Nucleoprotein Protein–Protein Interaction Journal of Medicinal Chemistry ·Benjamin R. Taft,Matthew J. Hesse,Mulugeta Mamo,Dirksen E. Bussiere,Richard S.P. Huang,Patrick S. Lee,Laura Wedel,Ellena Growcott,Karen C. Wolff,Kelli Kuhen,Johanna R. Abend,Kelly A. Wong,Don Ganem,Vincent H. J. Léonard,David C. Tully	2025	1
4	Synthesis and Structure-Activity Relationship of Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease with Antiviral Potency Bioorganic & Medicinal Chemistry Letters ·C. Rouch,Arnab K. Chatterjee,Connor McCarty,Lirui Song,Alan Chu,Kristen Johnson,Mina Heacock,Laura Riva,Case W. McNamara,Karen C. Wolff,Rebecca Greene-Cramer,Anna De Falco,G.T. Montelione,Gennadii A. Grabovyi	2024	0
5	Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling Virology ·Christopher S. McAllister,Dan Ansaldi,Ellena Growcott,Zhong Yang,Doug Quackenbush,Karen C. Wolff,Zhong Chen,Olga Tanaseichuk,G. Lelais,S. Whitney Barnes,Glenn C. Federe,Fabio Luna,John R. Walker,Yingyao Zhou,Kelli Kuhen	2019	10
6	RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment Virology ·Zhiqun Li,Karen C. Wolff,Charles E. Samuel	2009	70
7	Identification of novel therapeutic targets for HIV infection through functional genomic cDNA screening Virology ·Deborah G. Nguyen,Hong Yin,Yingyao Zhou,Karen C. Wolff,Kelli Kuhen,Jeremy S. Caldwell	2007	29
8	Chemical Genetic Identification of Glutamine Phosphoribosylpyrophosphate Amidotransferase as the Target for a Novel Bleaching Herbicide in Arabidopsis PLANT PHYSIOLOGY ·Terence A. Walsh,Teresa Bauer,Roben Neal,Ann Owens Merlo,Paul R. Schmitzer,Glenn R. Hicks,Mary Honma,Wendy Matsumura,Karen C. Wolff,John P. Davies	2007	26
9	Design, synthesis, and biological evaluations of novel quinolones as HIV-1 non-nucleoside reverse transcriptase inhibitors Bioorganic & Medicinal Chemistry Letters ·David Ellis,Kelli Kuhen,Beth Anaclerio,Baogen Wu,Karen C. Wolff,Hong Yin,Badry Bursulaya,Jeremy S. Caldwell,Donald S. Karanewsky,Yun He	2006	77
10	Mutations in an Auxin Receptor Homolog AFB5 and in SGT1b Confer Resistance to Synthetic Picolinate Auxins and Not to 2,4-Dichlorophenoxyacetic Acid or Indole-3-Acetic Acid in Arabidopsis PLANT PHYSIOLOGY ·Terence A. Walsh,Roben Neal,Ann Owens Merlo,Mary Honma,Glenn R. Hicks,Karen C. Wolff,Wendy Matsumura,John P. Davies	2006	183
11	Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1 Bioorganic & Medicinal Chemistry Letters ·Baogen Wu,Kelli Kuhen,Truc N. Nguyen,David Ellis,Beth Anaclerio,Xiaohui He,Kunyong Yang,Donald S. Karanewsky,Hong Yin,Karen C. Wolff,Kimberly Bieza,Jeremy S. Caldwell,Yun He	2006	17
12	Just-in-Time Purification: An Effective Solution for Cherry-Picking and Purifying Active Compounds from Large Legacy Libraries SLAS DISCOVERY ·Christina Guintu,Michael Kwok,James J. Hanlon,Tracy A. Spalding,Karen C. Wolff,Hong Yin,Kelli Kuhen,Kimberly Sasher,Paul Calvin,Shumei Jiang,Yingyao Zhou,John Isbell	2006	3
13	Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I Bioorganic & Medicinal Chemistry Letters ·Tao Jiang,Kelli Kuhen,Karen C. Wolff,Hong Yin,Kimberly Bieza,Jeremy S. Caldwell,Badry Bursulaya,Tom Yao‐Hsing Wu,Yun He	2006	265
14	Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2 Bioorganic & Medicinal Chemistry Letters ·Tao Jiang,Kelli Kuhen,Karen C. Wolff,Hong Yin,Kimberly Bieza,Jeremy S. Caldwell,Badry Bursulaya,Tove Tuntland,Kanyin Zhang,Donald S. Karanewsky,Yun He	2006	177
15	Design, Synthesis and Biological Evaluations of Novel Oxindoles as HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors. Part 1. ChemInform ·Tao Jiang,Kelli Kuhen,Karen C. Wolff,Hong Yin,Kimberly Bieza,Jeremy S. Caldwell,Badry Bursulaya,Tom Yao‐Hsing Wu,Yun He	2006	5
16	Homogeneous High-Throughput Screening Assays for HIV-1 Integrase 3'-Processing and Strand Transfer Activities SLAS DISCOVERY ·Yu Wang,Heath E. Klock,Hong Yin,Karen C. Wolff,Kimberly Bieza,Kirk Niswonger,Jason Matzen,Drew Gunderson,Joanna Hale,Scott A. Lesley,Kelli Kuhen,Jeremy S. Caldwell,Achim Brinker	2005	28
17	“UnPAKing” Human Immunodeficiency Virus (HIV) Replication: Using Small Interfering RNA Screening To Identify Novel Cofactors and Elucidate the Role of Group I PAKs in HIV Infection Journal of Virology ·Deborah G. Nguyen,Karen C. Wolff,Hong Yin,Jeremy S. Caldwell,Kelli Kuhen	2005	56
18	Vaccinia Virus E3L Interferon Resistance Protein Inhibits the Interferon-Induced Adenosine Deaminase A-to-I Editing Activity Virology ·Yong Liu,Karen C. Wolff,Bertram L. Jacobs,Charles E. Samuel	2001	56
19	Corrosion monitoring with speckle correlation Applied Optics ·Thomas Fricke-Begemann,Gerd Gülker,Klaus D. Hinsch,Karen C. Wolff	1999	34
20	Psychiatric Disability: Clinical, Legal, and Administrative Dimensions American Journal of Occupational Therapy ·Karen C. Wolff	1989	2

About Karen C. Wolff

Karen C. Wolff is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 20 papers that have together received 1.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Biochemical and Molecular Research (3 papers), Respiratory viral infections research (2 papers), RNA regulation and disease (2 papers), RNA Interference and Gene Delivery (2 papers) and Viral Infections and Immunology Research (2 papers). The work is most often cited by research in Virology (109 citations), Organic Chemistry (489 citations) and Infectious Diseases (106 citations). Karen C. Wolff has collaborated with scholars based in United States, Germany and Colombia. Frequent co-authors include Kelli Kuhen, Jeremy S. Caldwell, Hong Yin, Yun He, Badry Bursulaya, Tao Jiang, Charles E. Samuel, Glenn R. Hicks, John P. Davies and Terence A. Walsh. Their work appears in journals such as Journal of the American Chemical Society, PLANT PHYSIOLOGY and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact